Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001437749-25-025753
Filing Date
2025-08-08
Accepted
2025-08-11 14:26:29
Documents
17
Effectiveness Date
2025-08-08

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tgtx20250722_s8.htm S-8 78808
2 EXHIBIT 5.1 ex_841927.htm EX-5.1 7113
3 EXHIBIT 23.2 ex_849642.htm EX-23.2 3013
4 EXHIBIT FILING FEES ex_841928.htm   iXBRL EX-FILING FEES 16225
5 image1.jpg GRAPHIC 4493
6 pic1.jpg GRAPHIC 3583
7 pic2.jpg GRAPHIC 2743
  Complete submission text file 0001437749-25-025753.txt   240439

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT ex_841928_htm.xml XML 4819
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

EIN.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-289478 | Film No.: 251201483
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)